Suppression of hepatitis b virus by a combined activity of CRISPR/Cas9 and HBx proteins
Chronic hepatitis B is a severe liver disease associated with persistent infection with hepatitis B virus. According to recent estimations, 250 million people in the world are chronically infected, including 3 million chronically infected people in Russia. Antiviral therapeutics (nucleos(t)ide analo...
Guardado en:
Autores principales: | S. A. Brezgin, A. P. Kostyusheva, V. N. Simirsky, E. V. Volchkova, D. S. Chistyakov, D. S. Kostyushev, V. P. Chulanov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46e337894222405ebf01cb8c6a0c49f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis B virus and site-specific nucleases: effects of genetic modifications in CRISPR/Cas9 on antiviral activity
por: A. P. Kostyusheva, et al.
Publicado: (2019) -
Canonical and Divergent N-Terminal HBx Isoform Proteins Unveiled: Characteristics and Roles during HBV Replication
por: Sergio Hernández, et al.
Publicado: (2021) -
Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer
por: Xueke Wang, et al.
Publicado: (2021) -
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
por: N. P. Peretolchina, et al.
Publicado: (2016) -
CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions
por: Vladimir Chulanov, et al.
Publicado: (2021)